BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25680295)

  • 1. Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy.
    Ramaswamy K; Kheterpal E; Pham H; Mohan S; Stifelman M; Taneja S; Huang WC
    Clin Genitourin Cancer; 2015 Aug; 13(4):344-349. PubMed ID: 25680295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
    Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
    Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes.
    Nayak JG; Patel P; Saarela O; Liu Z; Kapoor A; Finelli A; Tanguay S; Rendon R; Moore R; Black PC; Lacombe L; Breau RH; Kawakami J; Drachenberg DE
    Urology; 2016 Aug; 94():154-60. PubMed ID: 27041471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
    Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
    PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
    Mouracade P; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Malkoc E; Kaouk JH
    World J Urol; 2017 Sep; 35(9):1425-1433. PubMed ID: 28197727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy.
    Russell CM; Lebastchi AH; Chipollini J; Niemann A; Mehra R; Morgan TM; Miller DC; Palapattu GS; Hafez KS; Sexton WJ; Spiess PE; Weizer AZ
    Urology; 2018 Jul; 117():95-100. PubMed ID: 29678662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and prognostic implications for pathologic upstaging to T3a after partial nephrectomy.
    Beksac AT; Paulucci DJ; Gul Z; Reddy BN; Kannappan M; Martini A; Sfakianos JP; Gin GE; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter J; Badani KK
    Minerva Urol Nefrol; 2019 Aug; 71(4):395-405. PubMed ID: 30230296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
    Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S; Eldefrawy A; Ghali F; Meagher MF; Hamilton ZA; Yim K; Nasseri R; Bradshaw AW; Dey S; Kirmiz S; Wan F; Liss MA; Bensalah K; Montorsi F; Derweesh IH
    Clin Genitourin Cancer; 2020 Dec; 18(6):e723-e729. PubMed ID: 32600941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumors.
    Senguttuvan Karthikeyan V; Mallya A; Sivaraman A; Galiano M; Rozet F; Cathala N; Barret E; Mombet A; Prapotnich D; Sanchez-Salas R; Cathelineau X
    Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):234-240. PubMed ID: 30857765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors.
    Veccia A; Falagario U; Martini A; Marchioni M; Antonelli A; Simeone C; Cormio L; Capitanio U; Mir MC; Derweesh I; Van Poppel H; Porpiglia F; Autorino R
    Eur Urol Focus; 2021 May; 7(3):574-581. PubMed ID: 32571744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does renal tumor biopsies for small renal carcinoma increase the risk of upstaging on final surgery pathology report and the risk of recurrence?
    Asselin C; Finelli A; Breau RH; Mallick R; Kapoor A; Rendon RA; Tanguay S; Pouliot F; Fairey A; Lavallée LT; Bladou F; Kawakami J; So AI; Richard PO
    Urol Oncol; 2020 Oct; 38(10):798.e9-798.e16. PubMed ID: 32693974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset.
    Veccia A; Antonelli A; Minervini A; Mottrie A; Dell'Oglio P; Ashrafi AN; Larcher A; Eun D; Bradshaw A; Amparore D; Brassetti A; Hampton LJ; Simeone C; Mari A; Carini M; De Naeyer G; Yang K; Capitanio U; Simone G; Porpiglia F; Derweesh I; Aron M; Autorino R
    Urol Oncol; 2020 Apr; 38(4):286-292. PubMed ID: 31956077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic features of upstaged pT3a renal tumors with fat invasion after robot-assisted partial nephrectomy: is it time for a new subclassification?
    Di Maida F; Campi R; Grosso AA; Lambertini L; Cadenar A; Giudici S; Pecoraro A; Mari A; Serni S; Minervini A;
    Eur J Surg Oncol; 2023 Apr; 49(4):862-867. PubMed ID: 36528511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preoperative predictive factors for pathological T3a upstaging and positive surgical margin of clinical T1 renal cell carcinoma.
    Çil G; Yilmaz M; Sahin Y; Ulus I; Canıtez IO; Kandıralı IE
    Actas Urol Esp (Engl Ed); 2024 May; 48(4):311-318. PubMed ID: 38369290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological upstaging of clinical T1 renal cell carcinoma: an analysis of 115,835 patients from National Cancer Data Base, 2004-2013.
    Ghanie A; Formica MK; Wang D; Bratslavsky G; Stewart T
    Int Urol Nephrol; 2018 Feb; 50(2):237-245. PubMed ID: 29247309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic surgery does not affect upstaging of T1 renal masses.
    Davaro F; Roberts J; May A; McFerrin C; Siddiqui S; Hamilton Z
    J Robot Surg; 2020 Jun; 14(3):447-454. PubMed ID: 31456083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
    Shah PH; Moreira DM; Patel VR; Gaunay G; George AK; Alom M; Kozel Z; Yaskiv O; Hall SJ; Schwartz MJ; Vira MA; Richstone L; Kavoussi LR
    J Urol; 2017 Aug; 198(2):289-296. PubMed ID: 28274620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy.
    Lee H; Lee M; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
    BMC Cancer; 2018 Apr; 18(1):427. PubMed ID: 29661179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High R.E.N.A.L. Nephrometry scores are associated with pathologic upstaging of clinical T1 renal-cell carcinomas in radical nephrectomy specimens: implications for nephron-sparing surgery.
    Tay MH; Thamboo TP; Wu FM; Zhaojin C; Choo TB; Ramaan L; Tiong HY
    J Endourol; 2014 Sep; 28(9):1138-42. PubMed ID: 24810993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.